Gary Small
Psychiatry · Hackensack, NJNPI 1295842946
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $131,660 of the $170,216 with a category attached, or 77.3%. 12 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 53.3% of the total. Reporting peaked in 2020 at $45,860 and has fallen 100.0% since, to $14 in 2025. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $1091.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$91K
- Eisai Inc.$18K
- Otsuka America Pharmaceutical, Inc.$17K
- Genentech USA, Inc.$13K
- Genentech, Inc.$7K
- Avanir Pharmaceuticals, Inc.$6K
- plus $20K from 6 others
What the payments were for
- Consulting fees$131,66077%
- Speaking & faculty fees$22,76013%
- Travel & lodging$12,6117%
- Food & beverage$2,9962%
- Education$1900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 75 | $90,759 |
| Eisai Inc. | 21 | $17,848 |
| Otsuka America Pharmaceutical, Inc. | 18 | $16,548 |
| Genentech USA, Inc. | 13 | $12,910 |
| Genentech, Inc. | 10 | $6,793 |
| Avanir Pharmaceuticals, Inc. | 1 | $5,775 |
| AbbVie | 9 | $5,471 |
| F. Hoffmann-la Roche AG | 1 | $5,280 |
| Biogen | 3 | $4,520 |
| Corium, LLC | 3 | $4,275 |
| Lundbeck LLC | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$76,638
- Leqembi$17,523
- REXULTI$14,196
- DISEASE EDUCATION$12,350
- Non-Covered Product$11,330
- NUEDEXTA$5,775
- ADLARITY$4,275
How this compares
$170,216 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Hackensack
- Syed ZaidiHackensack$57K
- Joseph AcquavivaHackensack$12K
- Mark FloodHackensack$9K
- Daniel CarreroHackensack$8K
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Leon RosenbergCherry Hill$257K
- Lloyd AlceraMarlton$187K
- Shankar SrinivasanParsippany$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.